Home
Venus Remedies Ltd Board of Directors
Board of Directors at Venus Remedies Ltd
Whole-time Director
Executive Director
Independent Director
Joint Managing Director
Independent Director
Key Highlights
- Pawan Chaudhary continues to serve as the Chairman & Managing Director in 2025, maintaining the same position as in the previous year.
- Manu Chaudhary continues to serve as the Joint Managing Director in 2025, maintaining the same position as in the previous year.
- Peeyush Jain continues to serve as the Deputy Managing Director in 2025, maintaining the same position as in the previous year.
- Ashutosh Jain continues to serve as the Executive Director in 2025, maintaining the same position as in the previous year.
- Neha Kodan continues to serve as the Company Sec. & Compli. Officer in 2025, maintaining the same position as in the previous year.

Venus Remedies Ltd
NSE: VENUSREM
Share Price
Last Ten Days Market Price
Date | |
---|---|
17 Oct 2025 | 453.25 |
16 Oct 2025 | 459.8 |
15 Oct 2025 | 460.85 |
14 Oct 2025 | 452.9 |
13 Oct 2025 | 451.9 |
10 Oct 2025 | 461 |
09 Oct 2025 | 448.9 |
08 Oct 2025 | 453.65 |
07 Oct 2025 | 463.05 |
06 Oct 2025 | 471.1 |
Company Fundamentals for Venus Remedies Ltd
Market Cap
605 Cr
EPS
35.0
P/E Ratio (TTM)
13.0
P/B Ratio (TTM)
1.1
Day’s High
456.3
Day’s Low
448.85
DTE
0.0
ROE
7.0
52 Week High
565.95
52 Week Low
272.2
ROCE
11.0
Market Price of Venus Remedies Ltd
1M
1Y
3Y
5Y
Venus Remedies Ltd News Hub
Venus Remedies consolidated net profit rises 3.39% in the June 2024 quarter
Net profit of Venus Remedies rose 3.39% to Rs 1.22 crore in the quarter ended June 2024 as against R
Read more
14 Aug 24
Venus Remedies to discuss results
Venus Remedies will hold a meeting of the Board of Directors of the Company on 13 August 2024. Power
Read more
03 Aug 24
Venus Remedies AGM scheduled
Venus Remedies announced that the 35th Annual General Meeting (AGM) of the company will be held on 2
Read more
24 Aug 24
Venus Remedies to table results
Venus Remedies will hold a meeting of the Board of Directors of the Company on 29 October 2024. Powe
Read more
18 Oct 24